Google DeepMind launches AlphaGenome 2 to study genetic variants by single cell type
Google DeepMind unveiled AlphaGenome 2, which analyzes genetic variants for individual cell types instead of bulk tissue and was trained on more than 107 million cell profiles. It finds nearly twice as many disease-relevant gene changes as the earlier version and is available for noncommercial research through an API.
Why it matters
Researchers studying genetic diseases get a more precise tool that could help find which cells are affected by a mutation.
aii.news picks and summarizes stories from trusted news sources with the help of AI. Every story links to the original reporting. How we work.